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CASE REPORT
Acral-type Malignant Acanthosis Nigricans Associated 
with Gastric Adenocarcinoma
Sang-Sin Lee, M.D., Nam-Ji Jung, M.D., Myung Im, M.D.,Young Lee, M.D., Young-Joon Seo, M.D., 
Jeung-Hoon Lee, M.D.
Department of Dermatology, School of Medicine, Chungnam National University,  Daejeon, Korea
Acanthosis nigricans is a symmetric eruption characterized 
by the presence of a hyperpigmented, velvety cutaneous 
thickening, that can develop on any part of the body, but 
characteristically affects the flexural areas of the body. The 
velvety hyperkeratotic lesions can be located on the dorsum 
of the hands and feet in dark-skinned people in the form of 
a variant of acanthosis nigricans called as acral acanthotic 
anomaly or acral type acanthosis nigricans. Although acan-
thosis nigricans is associated with malignant tumors, par-
ticularly gastric carcinoma, acral type acanthosis nigricans 
has never been reported to be associated with gastric adeno-
carcinoma.  In our present study, we  describe a case of 58- 
year-old man with acral type acanthosis nigricans and its 
association  with carcinoma of the stomach; a marked impro-
vement was seen in the  skin condition of the patient  with 
chemotherapy. (Ann Dermatol 23(S2) S208∼S210, 2011)
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INTRODUCTION
The disease acanthosis nigricans is characterized by the 
presence of a thick macule with a brown velvet-like sur-
face
1. Lesions frequently occur in the axillary region, 
neck, inguinal region, antecubital fossa, and popliteal 
fossa. However, it can also be localized to the dorsa of the 
hand and foot, being referred to in such cases as acral- 
type acanthosis nigricans. According to the classification 
system of Schwartz
2, there are eight clinical disease types: 
benign, obesity-associated, syndromic, malignancy-asso-
ciated, unilateral, acral, drug-induced, and mixed-type. Of 
these, the forms associated with malignancy develop 
during the early stages of malignant tumor progression 
(occurrence of tumor in an internal organ). Although acral- 
type acanthosis nigricans commonly occurs in healthy 
black people, we herein report a case of acral-type acan-
thosis nigricans with gastric adenocarcinoma in a Korean 
patient.
CASE REPORT
A 58-year-old man visited us complaining of development 
of asymptomatic hyperpigmented patches in areas around 
the phalangeal (Fig. 1A) and tarsophalangeal joints (Fig. 
1b) from approximate time duration of three months. The 
skin condition was presented with symmetric dark-brown 
patches and papillomatous hypertrophy in the phalangeal 
and tarsophalangeal joints. No other cutaneous (including 
palm and sole) or mucosal findings were present. Besides 
these dermatologic symptoms (and mild weight loss), the 
overall status of the patient was relatively good. Serum 
levels of insulin-like growth factor-1, cholesterol and tri-
glycerides, and the results of thyroid and liver function 
tests, were all within normal limits. A tissue biopsy re-
vealed the presence of hyperkeratosis, papillomatosis, Acral-type Malignant Acanthosis Nigricans Associated with Gastric Adenocarcinoma
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Fig. 1. Velvety, ill-defined hyperpigmentation and papillary hypertrophy are seen at the joints of the fingers (A) and toes (B).
Fig. 2. The lesion at the finger joint shows hyperkeratosis, 
papillomatosis, and hyperpigmentation of the basal layer. Some
dermal papillae were projected upward in the form of 
finger-like projections (H&E, ×100).
increased melanin pigmentation along the tips and sides 
of rete ridges, and melanophages in the papillary dermis 
(Fig. 2). It also showed protrusion of the dermal papilla in 
a digitated form. During a subsequent medical check-up, 
gastroduodenofibroscopy showed the presence of ulcera-
tive lesions of irregular shape in the gastric fundus, while 
a tissue biopsy showed that anaplastic epithelial cells had 
infiltrated into the mucosa. Based on these findings, a 
diagnosis of gastric adenocarcinoma was made. The patient 
received anti-cancer chemotherapy for four months. Fol-
lowing the therapy, there was a marked improvement in 
the condition of skin lesions (Fig. 3). At the time of writing 
this report, one further round of chemotherapy was 
planned and the patient is still being followed-up.
DISCUSSION
The skin is the organ of the body that can be most easily 
and quickly assessed. In patients with systemic diseases, 
various types of dermatologic symptoms might occur. 
These symptoms may often provide clues as to whether 
the systemic disease is benign or malignant-systemic. 
Acanthosis nigricans is a well-established marker of malignant 
tumors, which occur  in the internal organs
1. In the present 
case of a 58-year-old man with no history of diabetes, 
obesity or drug use, skin lesions had developed three 
months prior to the diagnosis of gastric carcinoma, and 
there was great improvement with subsequent anti-cancer 
chemotherapy. Since the skin lesions occurred in the 
phalangeal and tarsophalangeal joints, we diagnosed this 
case as acral-type malignant acanthosis nigricans.
In acral-type acanthosis nigricans, lesions are localized to 
the knee, ankle, phalangeal joint and tarsophalangeal 
joints
3. It is often characterized by hyperpigmentation in 
the phalangeal joint. In 1981, Schwartz
3 reported a case of 
acanthosis nigricans in the hand and foot of a black 
patient (aged 60 years), and classified it as being acral- 
type. According to the author, acral-type acanthosis 
nigricans occurs in healthy black people and does not, on 
its own, necessitate the evaluation of afflicted patients for 
the possible presence of an internal malignancy. How-
ever, Melczer and Dvorszky
4 reported localization of 
acanthosis nigricans lesions to the acral region in patients 
with dermatofibrosarcoma protuberans. In addition, acral- 
type acanthosis nigricans may occur in patients with 
lymphoma
5. In the present case, acral-type acanthosis 
nigricans was accompanied by the presence of gastric 
adenocarcinoma. Collectively, these observations led us 
to conclude that acral-type acanthosis nigricans may also 
be accompanied with  internal malignant diseases and that SS Lee, et al
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Fig. 3. (A, B) Treatment with anti-cancer chemotherapy improved the skin symptoms of acanthosis nigricans.
its presence may therefore necessitate a thorough search 
for underlying primary malignancies.
Tripe palms are rare paraneoplastic dermatosis, which are  
clinically characterized by the presence of thickened, 
velvety palms with pronounced dermatoglyphics. Its 
association with malignancy is high and frequently 
perceived in conjunction with acanthosis nigricans. In 
patients with both, triple palms and acanthosis nigricans, 
gastric carcinoma is most commonly followed by lung 
carcinoma
1. In our case, we could not find abnormal 
clinical findings on the patient’s palms. The patient’s 
acanthosis nigricans lesions were localized only around 
the phalangeal and tarsophalangeal joints.
Very little is known about the etiology and patho-
physiology of acral-type malignant acanthosis nigricans. It 
has been speculated, however, that tumor-secreted TGF-α 
(which acts on tumor cells in an autocrine fashion) is 
transported via the blood to the skin, where it binds to 
receptors on epidermal keratinocytes, thereby promoting 
their proliferation
6. The observation that following chemo-
therapy, there was an apparent disappearance of papillo-
matosis suggests a chemotherapeutic effect on the factor 
determining epidermal growth leading to acanthosis 
nigricans as seen in our patient. An inhibitory effect on the 
factors affecting epidermal proliferation is assumed, because 
of the reduction in papillomatosis, as observed clinically. 
Ellis et al.
7 reported that treatment of the malignancy leads 
to an improvement in skin symptoms. There have been no 
published reports about the effects of cancer chemo-
therapy on the condition of skin lesions. Although we 
have not studied growth factor expression in our patient, it 
is something that chemotherapy may reduce by cont-
rolling cancer growth.
In conclusion, in patients presenting with hyperkeratotic 
plaques on the knee, ankle, and/or phalangeal and tarso-
phalangeal joints, acral-type acanthosis nigricans should 
be considered as a possible diagnosis and the potential 
presence of an associated internal malignancy must be 
evaluated.
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